{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:59:10Z","timestamp":1774450750898,"version":"3.50.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Colorectal cancer (CRC) ranks among the most common gastrointestinal cancers globally, with both its incidence and mortality rates showing an upward trend. In particular, the 5-year survival rate for stage IV CRC patients is only 14%. Conventional treatments such as chemotherapy and immunotherapy can lead to drug resistance, exacerbate gastrointestinal function damage, and induce immunosuppression. Sijunzi decoction (SJZD), as a fundamental formula of Traditional Chinese medicine (TCM), has been demonstrated to confer distinct advantages in treatment of CRC. Therefore, we designed this trial to explore the efficacy of SJZD for the treatment of advanced refractory CRC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A multicenter, randomized, double-blind, placebo-controlled trial is being conducted to assess the effectiveness of SJZD combined with standard therapy for treating advanced refractory CRC. Patients with advanced CRC will be recruited and randomly allocated to either the SJZD treatment group or the placebo group in a 1:1 ratio. Both groups will receive standard treatment. The intervention period will last for 6\u202fmonths, with follow-up assessments every 8 to 10\u202fweeks. Progression-free survival (PFS) is the main outcome measure. And the secondary outcomes contain duration of disease control (DDC), overall survival (OS), completion rate of chemotherapy, incidence of treatment-related adverse events, quality of survival scale score for tumor patients and changes in spleen deficiency patient-reported outcome (PRO) scores following the intervention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Expected outcomes<\/jats:title><jats:p>To the best of our knowledge, this trial marks the first clinical investigation into the therapeutic potential of SJZD for managing advanced refractory CRC. The primary aim of this study is to provide robust clinical evidence to support the integration of TCM with Western medicine in the treatment of advanced refractory CRC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>The trial was registered at Chinese Clinical Trial Registry, <jats:uri>http:\/\/www.chictr.org.cn<\/jats:uri> (Registration No: ChiCTR2200065434); Date: 2022-11-04.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1523913","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T07:46:04Z","timestamp":1742456764000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Sijunzi decoction granules for the treatment of advanced refractory colorectal cancer: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial"],"prefix":"10.3389","volume":"12","author":[{"given":"Shuchang","family":"Nie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyu","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenghua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangxian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yabin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanchen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2355703","DOI":"10.1080\/15384047.2024.2355703","article-title":"Eif3a mediates malignant biological behaviors in colorectal Cancer through the Pi3k\/Akt signaling pathway","volume":"25","author":"Huo","year":"2024","journal-title":"Cancer Biol Ther"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"101174","DOI":"10.1016\/j.tranon.2021.101174","article-title":"Global colorectal Cancer burden in 2020 and projections to 2040","volume":"14","author":"Xi","year":"2021","journal-title":"Transl Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.46234\/ccdcw2022.077","article-title":"Colorectal Cancer screening in China: status, challenges, and prospects - China, 2022","volume":"4","author":"Chen","year":"2022","journal-title":"China CDC Wkly"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2236364","DOI":"10.1080\/19490976.2023.2236364","article-title":"Colorectal Cancer and gut microbiota studies in China","volume":"15","author":"Wang","year":"2023","journal-title":"Gut Microbes"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1272\/jnms.JNMS.2022_89-310","article-title":"Recent advances in the treatment of colorectal Cancer: a review","volume":"89","author":"Shinji","year":"2022","journal-title":"J Nippon Med Sch"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1388250","DOI":"10.3389\/fsurg.2024.1388250","article-title":"Analysis of risk factors for postoperative recurrence of stage I colorectal Cancer: a retrospective analysis of a large population","volume":"11","author":"Wang","year":"2024","journal-title":"Front Surg"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/COC.0b013e318256f5dc","article-title":"Improvements in 5-year outcomes of stage ii\/iii rectal Cancer relative to Colon Cancer","volume":"36","author":"Renouf","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.3390\/cancers15123088","article-title":"Knockdown of Ubqln1 functions as a strategy to inhibit Crc progression through the Erk-C-Myc pathway","volume":"15","author":"Ni","year":"2023","journal-title":"Cancers (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"110402","DOI":"10.1016\/j.intimp.2023.110402","article-title":"The Onco-embryonic antigen Ror1 is a target of chimeric antigen T cells for colorectal Cancer","volume":"121","author":"Meng","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s40001-023-01468-x","article-title":"Grid2 interacting protein is a potential biomarker related to immune infiltration in colorectal Cancer","volume":"28","author":"Zhao","year":"2023","journal-title":"Eur J Med Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","article-title":"Metastatic colorectal Cancer: mechanisms and emerging therapeutics","volume":"44","author":"Shin","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"109570","DOI":"10.1016\/j.biopha.2019.109570","article-title":"Antitumor effects of immunity-enhancing traditional Chinese medicine","volume":"121","author":"Wang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"111044","DOI":"10.1016\/j.biopha.2020.111044","article-title":"Anticancer activities of Tcm and their active components against tumor metastasis","volume":"133","author":"Wang","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"15347354211020105","DOI":"10.1177\/15347354211020105","article-title":"Patient reported traditional Chinese medicine spleen deficiency syndrome (Tcm-Sds) scale for colorectal Cancer: development and validation in China","volume":"20","author":"Sun","year":"2021","journal-title":"Integr Cancer Ther"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.joim.2022.08.002","article-title":"Appraisal of treatment outcomes in integrative medicine using Metabonomics: taking non-alcoholic fatty liver disease with spleen deficiency syndrome as an example","volume":"20","author":"Dai","year":"2022","journal-title":"J Integr Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.21037\/atm.2019.09.136","article-title":"Efficacy and safety of Sijunzi decoction for chronic fatigue syndrome with spleen deficiency pattern: study protocol for a randomized, double-blind, placebo-controlled trial","volume":"7","author":"Dai","year":"2019","journal-title":"Ann Transl Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"115876","DOI":"10.1016\/j.jep.2022.115876","article-title":"Mechanism of Sijunzi decoction in the treatment of colorectal Cancer based on network pharmacology and experimental validation","volume":"302","author":"Shang","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/cgt.2017.25","article-title":"Kruppel-like factor 4 acts as a potential therapeutic target of Sijunzi decoction for treatment of colorectal Cancer","volume":"24","author":"Jie","year":"2017","journal-title":"Cancer Gene Ther"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal Cancer in 2020 and 2040: incidence and mortality estimates from Globocan","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s00384-018-3130-7","article-title":"The dark side of laparoscopic surgery for colorectal Cancer patients aged 75 years or older","volume":"33","author":"Chern","year":"2018","journal-title":"Int J Color Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"100145","DOI":"10.1016\/j.esmoop.2021.100145","article-title":"The Ema assessment of Pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal Cancer","volume":"6","author":"Trullas","year":"2021","journal-title":"ESMO Open"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e12798","DOI":"10.15252\/emmm.202012798","article-title":"Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal Cancer","volume":"13","author":"Lu","year":"2021","journal-title":"EMBO Mol Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.3390\/ijms24021702","article-title":"Current targeted therapy for metastatic colorectal Cancer","volume":"24","author":"Ohishi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"102976","DOI":"10.1016\/j.esmoop.2024.102976","article-title":"Prognostic value of specific Kras mutations in patients with colorectal peritoneal metastases","volume":"9","author":"Tonello","year":"2024","journal-title":"ESMO Open"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","article-title":"Colon Cancer, version 2.2021, Nccn clinical practice guidelines in oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1200\/JOP.2017.022152","article-title":"Molecular biomarkers for the evaluation of colorectal Cancer: guideline summary from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology","volume":"13","author":"Sepulveda","year":"2017","journal-title":"J Oncol Pract"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3390\/cancers16051029","article-title":"Recent advances in therapeutic strategies to improve colorectal Cancer treatment","volume":"16","author":"Gmeiner","year":"2024","journal-title":"Cancers (Basel)"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/ijms18010197","article-title":"Colorectal carcinoma: a general overview and future perspectives in colorectal Cancer","volume":"18","author":"Marmol","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejca.2018.12.019","article-title":"Treatment sequencing in metastatic colorectal Cancer","volume":"109","author":"Modest","year":"2019","journal-title":"Eur J Cancer"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.6004\/jnccn.2019.5014","article-title":"Nccn guidelines updates: management of metastatic colorectal Cancer","volume":"17","author":"Messersmith","year":"2019","journal-title":"J Natl Compr Cancer Netw"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"110170","DOI":"10.1016\/j.cbi.2022.110170","article-title":"Colon Cancer and colorectal Cancer: prevention and treatment by potential natural products","volume":"368","author":"Islam","year":"2022","journal-title":"Chem Biol Interact"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"887048","DOI":"10.3389\/fimmu.2022.887048","article-title":"Identification of genes related to 5-fluorouracil based chemotherapy for colorectal Cancer","volume":"13","author":"Huang","year":"2022","journal-title":"Front Immunol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s12885-017-3445-8","article-title":"The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal Cancer: a randomized trial (Gerico)","volume":"17","author":"Lund","year":"2017","journal-title":"BMC Cancer"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal Cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5582\/bst.2021.01318","article-title":"The positive role of traditional Chinese medicine as an adjunctive therapy for Cancer","volume":"15","author":"Zhang","year":"2021","journal-title":"Biosci Trends"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"15347354221144051","DOI":"10.1177\/15347354221144051","article-title":"Role of traditional Chinese medicine syndrome type, gut microbiome, and host immunity in predicting early and advanced stage colorectal Cancer","volume":"22","author":"Yan","year":"2023","journal-title":"Integr Cancer Ther"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1175811","DOI":"10.3389\/fphar.2023.1175811","article-title":"Sijunzi decoction granules in the prevention and treatment of recurrence of colorectal adenoma: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial","volume":"14","author":"Ni","year":"2023","journal-title":"Front Pharmacol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11655-007-0156-z","article-title":"Progress in research on applying Sijunzi decoction in treating digestive malignant tumor","volume":"13","author":"Wu","year":"2007","journal-title":"Chin J Integr Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e0264720","DOI":"10.1371\/journal.pone.0264720","article-title":"Assessment of the targeted effect of Sijunzi decoction on the colorectal Cancer microenvironment via the estimate algorithm","volume":"17","author":"Du","year":"2022","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12906-019-2498-4","article-title":"The modified Si-Jun-Zi decoction attenuates Colon Cancer liver metastasis by increasing macrophage cells","volume":"19","author":"Zhou","year":"2019","journal-title":"BMC Complement Altern Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1523913\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T07:46:08Z","timestamp":1742456768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1523913\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":41,"alternative-id":["10.3389\/fmed.2025.1523913"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1523913","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"article-number":"1523913"}}